About Biom'Up
Biom'Up is a company based in Saint-priest (France) founded in 2005. Biom'Up has raised $43.82 million across 6 funding rounds from investors including Bpifrance, Gimv and European Union. Biom'Up operates in a competitive market with competitors including Prytime Medical Devices, Abyrx, LifeBond, Surgrx and Obsidio, among others.
- Headquarter Saint-priest, France
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website biomup.com
- Social LinkedIn X
- Total Equity Funding$43.82M (USD)
in 6 rounds
- Latest Funding Round$5.6M (USD), Debt – Conventional
Aug 2019
- InvestorsBpifrance
& 12 more
Funding Insights of Biom'Up
Biom'Up has successfully raised a total of $43.82M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5.6 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43.82M
- Total Rounds 6
- Last Round Debt – Conventional — $5.6M
- First Round $8.82M
(Oct 2012)
- Investors Count 13
All 6 funding rounds of BiomUp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | $5.6M | Debt – Conventional | – | – | |
| May 2019 | $56,002 | Grant | – | – | |
| Dec 2018 | $3.43M | Debt – Conventional | – | – | |
| Apr 2018 | $30.79M | Debt – Conventional | – | – | |
| Sep 2015 | $34.99M | Series C | – | Gimv, Lundbeck Foundation | |
| Oct 2012 | $8.82M | Series B | – | APICAP, INNOBIO |
13 investors in total: 13 institutional.
Investors in Biom'Up
Biom'Up has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Gimv and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity investments are managed by the firm. | – | athyrium.com | New York, United States | |
Private equity firm | 1980 | gimv.com | Antwerp, Belgium | |
Smalt Capital is engaged in capital investment and renewable energy financing. | 2000 | smaltcapital.com | Marseille, France | |
Life science companies are funded through venture capital investments. | – | lundbeckfonden.com | Copenhagen, Denmark | |
- | – | sofimac-im.com | - | |
Pivate equity firm that focuses on investing in healthcare and nutrition companies | – | merieux-partners.com | Lyon, France | |
- | – | apicap.fr | - | |
Aquasourça is engaged in capital investment and real estate activities. | 2003 | aquasourca.com | Lyon, France | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Offers insurance, risk management, and training for health and territorial entities. | 1927 | sham.fr | Lyon, France |
Investor details for BiomUp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biom'Up
6 people are tracked at Biom'Up (6 in leadership).
| Name | Role | Group |
|---|---|---|
Etienne Binant | CEO | Leadership |
Patrice Ferrand | Chief Executive Officer | Leadership |
William D. Spotnitz | Chief Medical Officer | Leadership |
Valérie Centis | Executive Vice President & Chief Scientific Officer | Leadership |
Thierry Darnis | Global Vice President, Manufacturing & Engineering | Leadership |
Evelyne Nguyen | Group CFO | Leadership |
Complete people profiles for Biom'Up
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biom'Up
4 dated milestones of Biom'Up across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Biom'Up is founded.
- Funding First funding round of $8.8M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $5.6M.
Competitors of Biom'Up
Biom'Up operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prytime Medical Devices, Abyrx, LifeBond, Surgrx and Obsidio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prytimemedical.com | 2011 | Boerne, United States | $10M | 41 | Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients | |
| abyrx.com | 2013 | Irvington, United States | $10M | – | Hemostatic bone putty is developed for surgical bone bleeding control. | |
| life-bond.com | 2007 | Caesarea, Israel | $56.5M | – | Absorbable surgical sealants and hemostats are developed for leakage prevention. | |
| surgrx.com | 2001 | Redwood, United States | $62.5M | – | Tissue sealing and hemostasis systems are developed for laparoscopic surgery. | |
| obsidiomed.com | 2018 | Solana Beach, United States | $3M | – | Shear-thinning biomaterial is developed to control blood flow minimally invasively. | |
| endomedix.com | 2005 | Newark, United States | $1.99M | – | Hydrogel solutions for surgery and wound care are developed. | |
| archtherapeutics.com | 2006 | Natick, United States | $320,000 | 8 | Hemostasis and sealant technology | |
| novuson.com | 2014 | Bothell, United States | $2.88M | 3 | Ultrasound devices for tissue ablation and hemostatic control are provided. | |
| z-medica.com | 2002 | Wallingford, United States | – | 124 | Hemostatic products for bleeding control are provided by Z-Medica. |
Detailed competitors of BiomUp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biom'Up
Websites that share an audience with Biom'Up (biomup.com).
Websites whose visitors overlap most with Biom'Up. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| atriummed.com | 100% | – | – | View details | |
| ethicon.com | 100% | – | #764,405 | View details | |
| dotmed.com | 100% | – | #118,835 | View details | |
| lookfordiagnosis.com | 100% | – | #8,871,571 | View details | |
| pharmaceutical-business-review.com | 60% | – | #2,626,966 | View details |
Latest news on Biom'up
Complete news archive for BiomUp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Biom'Up
10 companies that operate in the same segment as Biom'Up (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biom'Up
Biom'Up was founded in 2005 and raised its 1st funding round 7 years after it was founded.
Biom'Up is headquartered in Saint-priest, France. It is registered at Saint-priest, Auvergne-rhone-alpes, France.
Etienne Binant is the current CEO of Biom'Up.
Biom'Up is a funded company, having raised a total of $43.82M across 6 funding rounds to date. The company's 1st funding round was a Series B of $8.82M, raised on Oct 2012.
BiomUp was founded in 2005 and is based in Saint Priest Bramefant, France. Operations are centered in the biotech sector, where hemostatic products for surgical use are developed. These include HEMOBLAST Bellows, an absorbable collagen-based material designed for biosurgery applications. Hemostasis is promoted, and surgical procedures are supported through these offerings. The focus remains on providing practical solutions for medical environments.
Biom'Up's top competitors include Prytime Medical Devices, Arch Therapeutics and LifeBond.
Biom'Up has 13 investors. Key investors include Bpifrance, Gimv, European Union, Athyrium Capital Management, and Sham.